FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Scope Health Optase Dry Eye Intense Drops Recall

Optase Dry Eye Intense Drops (Glycerin 0

SCOPE HEALTH · New York, NY

Risk level
Class II
Reported by FDA
May 6, 2026
Recall ID
D-0499-2026
Check your lot numberHow we source this data

Summary

Scope Health recalled Optase Dry Eye Intense Drops starting Apr 20, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0499-2026 on May 6, 2026. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.

Lot numbers, UPCs & expiration codes

Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0499-2026
Classification
Class II
Status
Ongoing
Recall initiated
Apr 20, 2026
FDA report date
May 6, 2026
Recall type
Voluntary: Firm initiated
Recalling firm
SCOPE HEALTH

Original FDA data

Every field from FDA enforcement report D-0499-2026, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Ongoing
Country
United States
Event ID
98802
Address
79 Madison Avenue
Address (line 2)
27 E 28th St
Code information
Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.
Postal code
10016-7921
Report date
May 6, 2026
Product type
Drugs
Recall number
D-0499-2026
Classification
Class II
Recalling firm
SCOPE HEALTH
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
Distribution pattern
Nationwide within the United States
Recall initiation date
Apr 20, 2026
Initial firm notification
Letter
Center classification date
Apr 28, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0499-2026, published May 6, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls